Global market for stem cell research products in 2015 is estimated to be $1.2B

ARLINGTON, Va., March 19, 2015 /PRNewswire/ -- BioInformatics LLC has announced the release of their latest report, The Market for Stem Cell Research Products.

Stem cells are valued for their ability to self-renew and differentiate into a wide variety of different cell types. Because of their unique properties, stem cells are used in many different areas of health and medical research.

Market share, brand health and customer loyalty scores are presented for all leading competitors including Thermo Fisher, BD Biosciences, Sigma-Aldrich, StemCell Technologies, GE Healthcare and more.

Key findings from the report:

• The global market for stem cell research products in 2015 is estimated to be $1.2B
• The volume of stem cell media consumed is expected to increase by 11% in 2015
• 25% of respondents say they are highly likely to switch primary suppliers of stem cell research products in the next 12 months
• Chemically defined media is used by over half of the survey respondents

The Market for Stem Cell Research Products is the third in a series of topics to be explored using the Interactive Market Intelligence platform. The primary research analysis is based on a survey of 500+ international scientists using stem cells in their research.

See the report brochure (PDF) and Interactive Market Intelligence demo video.

Current and upcoming market studies available on the Interactive Market Intelligence platform:

The Market for Gene Editing & CRISPR (May 2015)
The Market for Real-Time PCR (Now Available)
The Market for Cell-Based Assays (Now Available)

Contact us at [email protected] for more information and for a demo consultation.

ABOUT BIOINFORMATICS LLC

Now celebrating 20 years in business, BioInformatics LLC and its SDi division form the premier research and advisory firm serving the life science and analytical instrument industries. By leveraging our expert network of more than 72,000 life scientists, the company has supported more than 500 companies in creating insights that lead to better business decisions. Offerings include assessing the size and attractiveness of scientific markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Zach French
Manager, Marketing & BD
BioInformatics LLC
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x19 (phone)
www.gene2drug.com

SOURCE BioInformatics LLC

Related Links

http://www.gene2drug.com